Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT06487975
NA

Bacillus Subtilis in Parkinson's Disease

Sponsor: University of Edinburgh

View on ClinicalTrials.gov

Summary

The aim of this study is to evaluate whether the administration of Bacillus Subtilis influences gut and blood biomarkers relevant to the proposed mechanism(s) of action, as well as being acceptable as a regular supplement for people with Parkinson's disease.

Official title: Effects of Bacillus Subtilis on Blood and Gut Biomarkers in Parkinson's Disease

Key Details

Gender

All

Age Range

50 Years - Any

Study Type

INTERVENTIONAL

Enrollment

26

Start Date

2023-05-02

Completion Date

2025-11-20

Last Updated

2026-04-08

Healthy Volunteers

No

Interventions

DIETARY_SUPPLEMENT

Bacillus Subtilis

Bacillus Subtilis 1 capsule once daily in the morning (consisting of 10x10\^9 Colony Forming Units)

OTHER

Placebo

1 visually identical placebo capsule once daily in the morning using the same carrier (microcrystalline cellulose) as the active (but not containing Bacillus Subtilis)

Locations (2)

Norwegian Centre for Movement Disorders, Stavanger University Hospital

Stavanger, Norway

NHS Lothian

Edinburgh, United Kingdom